In the all cash deal, Sun Pharma will acquire the shares at a price of US $38 per ordinary share, which will be payable in full at the close of the proposed transaction, the company said in a BSE filing on Saturday. At present, Sun holds 78.48% stake in Taro.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/Um6bo3t
via